Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AstraZeneca Secures $486 Million From U.S. Government for Coronavirus Antibody Cocktail


AstraZeneca (NYSE: AZN) has secured $486 million from the U.S. government's Biomedical Advanced Research and Development Authority to support the development of AZD7442, an antibody cocktail for the treatment and prevention of COVID-19.

For its support, BARDA will get up to 100,000 doses of the drug and has the option to purchase up to 1 million additional doses of the treatment in 2021. The company didn't disclose the value of the potential million-dose contract.

AZD7442 is a cocktail of two long-acting antibodies designed to last for six to 12 months, making it especially useful for long-term prevention of COVID-19.

Continue reading


Source Fool.com

Like: 0
AZN
Share

Comments